Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-018-2806-2
Abstract: Antibody therapy targeting specific molecules has been successfully used to treat various diseases including RCC, but some patients do not respond to the therapy (Motzer et al. 2015). There is an urgent need to develop… read more here.
Keywords: antibody therapy; rcc patients; develop companion; antibody ... See more keywords
Design of therapeutic vaccines as a novel antibody therapy for cardiovascular diseases.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of cardiology"
DOI: 10.1016/j.jjcc.2017.01.010
Abstract: Vaccines are primarily used worldwide as a preventive medicine for infectious diseases and have recently been applied to cancer. We and others have developed therapeutic vaccines designed for cardiovascular diseases that are notably different from… read more here.
Keywords: antibody therapy; antibody; cardiovascular diseases; cancer ... See more keywords
Copolyelectrolyte-Based Nanocapsules for Oral Monoclonal Antibody Therapy: A Mesoscale Modeling Survey.
Sign Up to like & getrecommendations! Published in 2022 at "Biomacromolecules"
DOI: 10.1021/acs.biomac.2c00699
Abstract: Antibody therapy generally requires parenteral injection to attain the required bioavailability and pharmacokinetics, but improved formulations may slow enzymatic degradation of the antibody in the gastrointestinal tract, permitting the use of noninvasive oral delivery. Rationally… read more here.
Keywords: based nanocapsules; antibody therapy; copolyelectrolyte based; antibody ... See more keywords
Antibody Therapy for COVID-19: Categories, Pros, and Cons.
Sign Up to like & getrecommendations! Published in 2022 at "Viral immunology"
DOI: 10.1089/vim.2021.0160
Abstract: COVID-19 is a life-threatening respiratory disease triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has been considered a pandemic viral infection since December 2019. The investigation of the effective prophylaxis or therapeutic strategies… read more here.
Keywords: covid categories; antibody therapy; antibody; categories pros ... See more keywords
Efficiency of antibody therapy in demyelinating diseases
Sign Up to like & getrecommendations! Published in 2017 at "International Immunology"
DOI: 10.1093/intimm/dxx037
Abstract: Monoclonal antibody therapy is a new treatment strategy for many types of diseases including cancers and autoimmune diseases, realizing a high efficacy and tolerability. In multiple sclerosis (MS) and neuromyelitis optica (NMO) spectrum disorders, several… read more here.
Keywords: antibody therapy; monoclonal antibodies; antibody; anti ... See more keywords
526. Implementation of Use of Monoclonal Antibody Therapy in a Large Academic Center for the Outpatient Treatment of Covid-19: Impact on 30 Day Hospitalization Rates, ED Visits and Death
Sign Up to like & getrecommendations! Published in 2021 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofab466.725
Abstract: Abstract Background Monoclonal Antibody Therapy (MAbs) has been shown to reduce rates of ED visits and hospitalizations in patients at risk for severe Covid-19 infection in clinical trials. Since November, three Mabs received emergency use… read more here.
Keywords: monoclonal antibody; antibody therapy; therapy; day ... See more keywords
Monoclonal Antibody Therapy for COVID-19: A Public Health Perspective From Arkansas
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofab602
Abstract: Abstract COVID-19 monoclonal antibodies revolutionized the treatment for eligible patients who have tested positive for SARS CoV-2 infection in an ambulatory setting. In this short report, we describe our experience assisting in the distribution of… read more here.
Keywords: health perspective; monoclonal antibody; covid public; public health ... See more keywords
Antibody therapy for COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Current Opinion in Allergy and Clinical Immunology"
DOI: 10.1097/aci.0000000000000787
Abstract: Purpose of review To provide an update of the current state of antibody therapy for Severe Acute Respiratory Syndrome Coronavirus 2 infection that has progressed immensely in a very short time period. Recent findings Limited… read more here.
Keywords: immunology; therapy; antibody therapy; therapy covid ... See more keywords
Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Sign Up to like & getrecommendations! Published in 2022 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000004700
Abstract: Anti-spike monoclonal antibody therapy may be effective for pregnant women with coronavirus disease 2019 (COVID-19). read more here.
Keywords: spike monoclonal; monoclonal antibody; antibody therapy; pregnant women ... See more keywords
Treatment of Transient Peripheral Neuropathy During Chimeric 14.18 Antibody Therapy in Children With Neuroblastoma: A Case Series
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000000889
Abstract: Children with high-risk neuroblastoma are currently treated with a chimeric monoclonal antibody against GD2 ganglioside (chimeric 14.18). The treatment improves survival but causes transient neuropathic pain-like syndrome. We retrospectively studied 16 children with neuroblastoma receiving… read more here.
Keywords: antibody therapy; treatment; antibody; children neuroblastoma ... See more keywords
Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
Sign Up to like & getrecommendations! Published in 2017 at "Science Advances"
DOI: 10.1126/sciadv.1602133
Abstract: Cooperative therapeutic effect of anti-CTLA4 and anti-sMIC antibodies. Antibody therapy targeting cytotoxic T lymphocyte–associated antigen 4 (CTLA4) elicited survival benefits in cancer patients; however, the overall response rate is limited. In addition, anti-CTLA4 antibody therapy… read more here.
Keywords: antibody therapy; anti ctla4; antibody; ctla4 antibody ... See more keywords